• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
John Lauerman

Stay informed with John Lauerman’s coverage and analysis.

What to know about a potential ‘second wave’ of COVID-19
HealthWhat to know about a potential ‘second wave’ of COVID-19
By John Lauerman and BloombergJune 12, 2020
Dr. Fauci’s worst nightmare? We’re living it
HealthDr. Fauci’s worst nightmare? We’re living it
By John Lauerman, Riley Griffin and BloombergJune 10, 2020
Hydroxychloroquine study shows deaths, heart risks in COVID-19 patients
HealthHydroxychloroquine linked to deaths and heart risks in new COVID-19 study after Trump touted and claimed to be taking the drug
By John Lauerman and BloombergMay 22, 2020
British pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
HealthBritish pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
By John Lauerman and BloombergMay 21, 2020
Coronavirus originated in bats, WHO says, but scientists also see link to cats, ferrets and pangolins
HealthCoronavirus originated in bats, WHO says, but scientists also see link to cats, ferrets and pangolins
By Janice Kew, John Lauerman and BloombergMay 8, 2020
Cambridge Biotech Moderna Leads in Race For Coronavirus Vaccine
WHO raises prospect of deliberately infecting healthy volunteers to speed up coronavirus vaccines
By Corinne Gretler, John Lauerman and BloombergMay 6, 2020
In race to make a coronavirus vaccine, AstraZeneca joins forces with Oxford University
HealthIn race to make a coronavirus vaccine, AstraZeneca joins forces with Oxford University
By Marthe Fourcade, John Lauerman and BloombergApril 30, 2020
LONDON, ENGLAND - APRIL 07: Media gather outside St Thomas' Hospital on April 07, 2020 in London, England. Prime Minister Boris Johnson was transferred to the intensive care unit at St Thomas' Hospital after his coronavirus symptoms worsened last night. (Photo by Justin Setterfield/Getty Images)
HealthWhat coronavirus hospital data tells us about ICU patients like Boris Johnson
By John Lauerman, Marthe Fourcade and BloombergApril 7, 2020
LONDON, UNITED KINGDOM - MARCH 26: In this photo illustration a pack of Hydroxychloroquine Sulfate medication is displayed on March 26, 2020 in London, United Kingdom. The Coronavirus (COVID-19) pandemic has spread to many countries across the world, claiming over 20,000 lives and infecting hundreds of thousands more. U.S. President Donald Trump recently promoted Hydroxychloroquine, a common anti-malaria drug, as a potential treatment for COVID-19 when combined with the antibiotic azithromycin. “HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine,” President Trump tweeted last week. (Photo by John Phillips/Getty Images)
HealthMalaria drug Trump touted as coronavirus treatment has been given FDA emergency authorization
By John Lauerman and BloombergMarch 30, 2020
Diabetes medicine pills
HealthFDA Is Testing Diabetes Drug Metformin for NDMA, a Carcinogen
By John Lauerman and BloombergDecember 4, 2019
1
  • 1
  • 2
2
Most Popular
Asia
Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese militaryplaceholder alt text
By Kate O'Keeffe and BloombergJune 8, 2026
Economy
'We are rapidly running out of time': Watchdog sounds Social Security alarm after 22% cut confirmed for 2032placeholder alt text
By Nick LichtenbergJune 9, 2026
Success
Costco CEO Ron Vachris rose from forklift driver to the C-suite without a college degree: ‘Don’t chase a title’ is the career advice that got him thereplaceholder alt text
By Preston ForeJune 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.